Merck Orders Worldwide Recall of Vioxx
497516
(Brooklyn-WABC, September 30, 2004) - A massive drug recall -- the arthritis drug Vioxx is now linked to a higher risk of heart attacks and stroke.
320680
Pharmaceutical titan Merck &amp; Co. Inc. yesterday pulled its blockbuster arthritis drug Vioxx off the market, citing safety concerns, thereby triggering a massive selloff in the company&#39;s shares that wiped out nearly US$27-billion of Merck&#39;s market value.
716149
VANCOUVER - Just days after the arthritis drug Vioxx was pulled from store shelves, a class action lawsuit has been launched in BC Supreme Court alleging negligence by drug maker Merck and Co.
80595
Pharmacists swept bottles of Vioxx off their shelves Thursday and braced for a round of calls from customers following a recall of the popular anti-inflammatory drug.
414077
NEW YORK -- Merck &amp; Co.'s campaign to defend itself in the wake of the recall of the pain reliever Vioxx intensified last week, as it placed a package of three full-page ads in seven prominent newspapers beginning last Friday. That follows several television appearances, as well as testimony before Congress by the company's chief executive.
210517
The European Medicines Agency is to review all drugs in the same class as Vioxx after US pharmaceutical giant Merck withdrew the arthritis drug.
66432
TRENTON, NJ -- Merck &amp; Co. withdrew best-selling arthritis drug Vioxx on Thursday after a study showed the drug doubled the risk of heart attacks and strokes.
753130
Merck &amp; Co. said on Thursday withdrew its arthritis drug Vioxx globally after a colon cancer trial confirmed long-standing concerns the drug raises the risk of heart attack and stroke.
300996
Research shows that the dangers linking the arthritis drug Vioxx, a COX-2 inhibitor, to an increased risk of heart attacks, were known in 2000, which should have led to its immediate recall.
292172
Merck &amp; Co., the second-largest US drugmaker, lost its AAA credit rating from Standard &amp; Poor&#39;s because of revenue losses and potential liabilities from the company&#39;s September recall of the Vioxx painkiller.
292772
As many as 15,000 New Zealanders will be forced to find an alternative form of pain relief after the worldwide recall of the drug Vioxx, which has been found to double the risk of heart attacks and strokes.
33474
On September 30, 2004, Merck &amp; Co. announced the immediate recall of one of its COX-2 inhibitors, the anti-inflammatory drug VIOXXÂ®, because, in Merck&#39;s own words, a study it had been conducting showed that:
206148
Merck reduced its 2004 forecast by 50 cents to 55 cents because of lost revenues. The move followed the recall of Vioxx from the global market on September 30th, due to its association with increased risk of heart attacks.
766348
U.S. drugs giant Merck & Co Inc. should  have pulled its Vioxx painkiller from the market four years ago  because data showing it raised the risk of heart attacks has  existed since 2000, Swiss scientists said on Friday.
283133
Merck & Co. said on Thursday withdrew its arthritis drug Vioxx globally after a colon cancer trial confirmed long-standing concerns the drug raises the risk of heart attack and stroke.
316389
MERCK faces a fresh barrage of lawsuits over its Vioxx arthritis drug that together could cost it as much as $18 billion (Â£9.8 billion) as hundreds of lawyers from across America will next week team up for a combined attack on the embattled drug
628834
Merck & Co Inc. on Thursday pulled its  arthritis drug Vioxx off the market after a study showed it  doubled the risk of heart attack and stroke, a move that sent  its shares plunging and erased $25 billion from its market  value.